Real-world experience of afatinib as first-line therapy for advanced <i>EGFR</i> mutation-positive non-small cell lung cancer in Korea.

Lee, Sung Yong; Choi, Chang-Min; Chang, Yoon Soo; Lee, Kye Young; Kim, Seung Joon; Yang, Sei Hoon; Ryu, Jeong Seon; Lee, Jeong Eun; Lee, Shin Yup; Park, Ji Young; Kim, Young-Chul; Oh, In-Jae; Jung, Chi Young; Lee, Sang Hoon; Yoon, Seong Hoon; Choi, Juwhan; Jang, Tae Won

Real-world experience of afatinib as first-line therapy for advanced EGFR mutation-positive non-small cell lung cancer in Korea.

Lee, Sung Yong; Choi, Chang-Min; Chang, Yoon Soo; Lee, Kye Young; Kim, Seung Joon; Yang, Sei Hoon; Ryu, Jeong Seon; Lee, Jeong Eun; Lee, Shin Yup; Park, Ji Young; Kim, Young-Chul; Oh, In-Jae; Jung, Chi Young; Lee, Sang Hoon; Yoon, Seong Hoon; Choi, Juwhan; Jang, Tae Won.

Afiliación

Lee SY; Korea University Guro Hospital, Seoul, South Korea.
Choi CM; Ulsan University Asan Medical Center, Seoul, South Korea.
Chang YS; Yonsei University Gangnam Severance Hospital, Seoul, South Korea.
Lee KY; Konkuk University Medical Center, Seoul, South Korea.
Kim SJ; Catholic University Seoul St. Mary's Hospital, Seoul, South Korea.
Yang SH; Wonkwang University Hospital, Iksan, South Korea.
Ryu JS; Inha University Hospital, Incheon, South Korea.
Lee JE; Chungnam National University, Daejeon, South Korea.
Lee SY; Kyungpook National University Chilgok Hospital, Daegu, South Korea.
Park JY; Hallym University Sacred Heart Hospital, Anyang, South Korea.
Kim YC; Chonnam National University Medical School and Hwasun Hospital, Hwasun, South Korea.
Oh IJ; Chonnam National University Medical School and Hwasun Hospital, Hwasun, South Korea.
Jung CY; Daegu Catholic University Medical Center, Daegu, South Korea.
Lee SH; Yonsei University Severance Hospital, Seoul, South Korea.
Yoon SH; Pusan National University Yangsan Hospital, Yangsan, South Korea.
Choi J; Korea University Guro Hospital, Seoul, South Korea.
Jang TW; Kosin University Gospel Hospital, Busan, South Korea.

Transl Lung Cancer Res ; 10(12): 4353-4367, 2021 Dec.

Article en En | MEDLINE | ID: mdl-35070746

Palabras clave

Afatinib; epidermal growth factor receptor (EGFR); first-line; non-small cell lung cancer (NSCLC); real-world

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Transl Lung Cancer Res Año: 2021 Tipo del documento: Article País de afiliación: Corea del Sur Pais de publicación: China

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google